Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 1, 2006, Pages 100-110

  Gaster, Michael ^a   Beck Nielsen, Henning ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Glucose metabolism; Insulin resistance; Lipid metabolism; Oleic acid; Palmitic acid; Skeletal muscle; T2D

Indexed keywords

ANTIMYCIN A1; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; OLEIC ACID; OLIGOMYCIN; PALMITIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID OXIDATION; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

CELLS, CULTURED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLYCOGEN; HUMANS; MIDDLE AGED; MUSCLE FIBERS; OBESITY; REFERENCE VALUES; TRIGLYCERIDES;

EID: 33646065654     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2005.12.003     Document Type: Article

References (55)

1. Anderwald C., Bernroider E., Krssak M., Stingl H., Brehm A., Bischof M.G., Nowotny P., Roden M., and Waldhausl W. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51 (2002) 3025
2. Bachmann O.P., Dahl D.B., Brechtel K., Machann J., Haap M., Maier T., Loviscach M., Stumvoll M., Claussen C.D., Schick F., Haring H.U., and Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50 (2001) 2579
3. Beck-Nielsen H., and Groop L.C. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J. Clin. Invest.. 94 (1994) 1714
4. Boden G., Chen X., Ruiz J., White J.V., and Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93 (1994) 2438
5. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., Coleman E., and Smith C. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88 (1991) 960
6. Boden G., Lebed B., Schatz M., Homko C., and Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50 (2001) 1612
7. Bogardus C., Lillioja S., Stone K., and Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J. Clin. Invest. 73 (1984) 1185
8. Bonen A., Benton C.R., Campbell S.E., Chabowski A., Clarke D.C., Han X.X., Glatz J.F., and Luiken J.J. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes. Acta Physiol. Scand. 178 (2003) 347
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248
10. Chavez J.A., Knotts T.A., Wang L.P., Li G., Dobrowsky R.T., Florant G.L., and Summers S.A. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 278 (2003) 10297
11. Chavez J.A., and Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419 (2003) 101
12. Ciaraldi T.P., Abrams L., Nikoulina S., Mudaliar S., and Henry R.R. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 96 (1995) 2820
13. Damsbo P., Vaag A., Hother-Nielsen O., and Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34 (1991) 239
14. Ellis B.A., Poynten A., Lowy A.J., Furler S.M., Chisholm D.J., Kraegen E.W., and Cooney G.J. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol.: Endocrinol. Metab. 279 (2000) E554-E560
15. Gaster M., and Beck-Nielsen H. The reduced insulin mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin-evidence from cultured myotubes. Biochim. Biophys. Acta 1690 (2004) 85
16. Gaster M., Kristensen S.R., Beck-Nielsen H., and Schroder H.D. A cellular model system of differentiated human myotubes. APMIS 109 (2001) 735
17. Gaster M., Ottosen P.D., Vach W., Christiansen H., Staehr P., Beck-Nielsen H., and Schroder H.D. GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?. APMIS 111 (2003) 338
18. Gaster M., Petersen I., Hojlund K., Poulsen P., and Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51 (2002) 921
19. Gaster M., Rustan A., and Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate. Evidence from cultured myotubes. Diabetes 54 (2005) 648
20. Gaster M., Rustan A.C., Aas V., and Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53 (2004) 542
21. Gaster M., Schroder H.D., Handberg A., and Beck-Nielsen H. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochim. Biophys. Acta 1537 (2001) 211
22. Goodpaster B.H., He J., Watkins S., and Kelley D.E. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab 86 (2001) 5755
23. Goodpaster B.H., Thaete F.L., and Kelley D.E. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am. J. Clin. Nutr. 71 (2000) 885
24. Goodpaster B.H., Thaete F.L., Simoneau J.A., and Kelley D.E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46 (1997) 1579
25. Hansen L., Gaster M., Oakeley E.J., Brusgaard K., Damsgaard Nielsen E.M., Beck-Nielsen H., Pedersen O., and Hemmings B.A. Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes. Biochem. Biophys. Res. Commun. 323 (2004) 685
26. He J., Watkins S., and Kelley D.E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50 (2001) 817
27. Hegarty B.D., Cooney G.J., Kraegen E.W., and Furler S.M. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51 (2002) 1477
28. Helge J.W., and Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity?. Diabetes 52 (2003) 1881
29. Henry R.R., Ciaraldi T.P., Abrams-Carter L., Mudaliar S., Park K.S., and Nikoulina S.E. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J. Clin. Invest. 98 (1996) 1231
30. Henry R.R., Ciaraldi T.P., Mudaliar S., Abrams L., and Nikoulina S.E. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 45 (1996) 400
31. Jacobs A.E., Oosterhof A., and Veerkamp J.H. Palmitate oxidation and some enzymes of energy metabolism in human muscles and cultured muscle cells. Int. J. Biochem. 19 (1987) 1049
32. Kase E.T., Wensaas A.J., Aas V., Hojlund K., Levin K., Thoresen G.H., Beck-Nielsen H., Rustan A.C., and Gaster M. Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 54 (2005) 1108
33. Kelley D.E., Goodpaster B., Wing R.R., and Simoneau J.A. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277 (1999) E1130-E1141
34. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944
35. Kelley D.E., Mokan M., Simoneau J.A., and Mandarino L.J. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92 (1993) 91
36. Kim J.K., Wi J.K., and Youn J.H. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes 45 (1996) 651
37. Kraegen E.W., Clark P.W., Jenkins A.B., Daley E.A., Chisholm D.J., and Storlien L.H. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40 (1991) 1397
38. Krssak M., Falk P.K., Dresner A., DiPietro L., Vogel S.M., Rothman D.L., Roden M., and Shulman G.I. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42 (1999) 113
39. Laughton C. Quantification of attached cells in microtiter plates based on Coomassie brilliant blue G-250 staining of total cellular protein. Anal. Biochem. 140 (1984) 417
40. Laughton C. Measurement of the specific lipid content of attached cells in microtiter cultures. Anal. Biochem. 156 (1986) 307
41. Levin K., Daa S.H., Alford F.P., and Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44 (2001) 824
42. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., and Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267
43. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., and Kraegen E.W. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46 (1997) 1768
44. Ortenblad N., Mogensen M., Petersen I., Hojlund K., Levin K., Sahlin K., Beck-Nielsen H., and Gaster M. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta 1741 (2005) 206
45. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., Jenkins A.B., and Storlien L.H. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46 (1997) 983
46. Perdomo G., Commerford S.R., Richard A.M., Adams S.H., Corkey B.E., O'Doherty R.M., and Brown N.F. Increased Beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid induced insulin resistance despite intramyocellular lipid accumulation. J. Biol. Chem. 279 26 (2004) 27177-27186
47. Perseghin G., Scifo P., De Cobelli F., Pagliato E., Battezzati A., Arcelloni C., Vanzulli A., Testolin G., Pozza G., Del Maschio A., and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48 (1999) 1600
48. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664
49. Phillips D.I., Caddy S., Ilic V., Fielding B.A., Frayn K.N., Borthwick A.C., and Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45 (1996) 947
50. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., and Shulman G.I. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97 (1996) 2859
51. Schmitz-Peiffer C., Craig D.L., and Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem. 274 (1999) 24202
52. Shimabukuro M., Koyama K., Chen G., Wang M.Y., Trieu F., Lee Y., Newgard C.B., and Unger R.H. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. U. S. A 94 (1997) 4637
53. Simoneau J.A., Colberg S.R., Thaete F.L., and Kelley D.E. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 9 (1995) 273
54. Simoneau J.A., and Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83 (1997) 166
55. Skrede S., Bremer J., Berge R.K., and Rustan A.C. Stimulation of fatty acid oxidation by a 3-thia fatty acid reduces triacylglycerol secretion in cultured rat hepatocytes. J. Lipid Res. 35 (1994) 1395